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ABSTRACT
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Abstract
Fluorescent sensors have been widely used as microscopic tools to image Zn 2+
on a cellular level. Recently, it has been established that the sensors TSQ and Zinquin form
adducts with Zn-proteins and image fractions of the Zn-proteome.1 Since TSQ and Zinquin bind
specifically to many Zn-proteins, it is hypothesized that other metal binding ligands, both
synthetic and natural, may also bind to the Zn-proteome. Biologically active 1,10-phenanthroline
(Phen) and related molecules were investigated for their ability to bind to Zn-proteome.
Similarly, the cellular tripeptide, glutathione was investigated. It was observed that Phen and
some other metal binding, bidentate ligands, were able to displace TSQ from the TSQ-Znproteome. Specifically when cellular Zn-proteome reacted with TSQ, adduct formation occurs,
that was detected by fluorescence emission at 470 nm. Upon reaction of TSQ-Zn-proteome with
1,10-phenanthroline, glutathione, and some other related small molecules, a significant decrease
in fluorescence was observed, indicating the displacement of TSQ by each competing ligand.
Native SDS (NDS) PAGE electrophoresis of the product of the reaction of 1,10-Phenanthroline
with TSQ-Zn-proteome further confirmed the displacement of TSQ from an array of Zn-proteins.
This reaction was further characterized with the use of Zn-alcohol dehydrogenase as a model
enzyme that reacts with TSQ and Phen. These studies reveal the Zn-proteome as widely available
ii

for adduct formation at its zinc binding sites. The importance of such reactions is being
investigated.
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1. Introduction

1.1.

Zinc - its biological importance and regulation in the living organisms

Metal ions play pivotal roles in most biochemical processes.2–8 In fact, many proteins bind
to one or more metal ions to perform their functions. Such proteins are called metalloproteins.2
The incorporation of the metal ions is very critical because either the metal ions play a role in
the catalytic mechanism or because they determine or stabilize protein tertiary or quaternary
structure.2 The intracellular concentration of metals as well as their distribution among the
various cell compartments and their incorporation into metalloproteins are tightly controlled.9
The equilibria of the metal ions involved in the body and their proper control processes are
necessary to maintain a healthy phenotype.
Zn2+ is one of the biologically essential metal ions that is a key element in all forms
of life.1,4,6–8,10,11 It is the second most abundant divalent transition metal ion in living organisms
after iron. According to bioinformatics analysis, about 10% of the human genome has been
proposed to encode Zn-binding proteins.5,12 This translates into about 3000 Zn-binding proteins
that populate in the mammalian proteome.1,8,13–15 Zn2+ is involved in a wide range of protein
function; it participates in more than 300 cellular processes such as DNA transcription, protein
synthesis, neurotransmission, intracellular signaling, and antibiotic activities. 6,16
There are two types of zinc binding sites in the intracellular environment, Zn2+ tightly
bound to metalloproteins and also mobile forms of Zn2+.17
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Zinc is involved in the function of proteins, it participates in the control of cellular
metabolism and signaling.13 Roles of zinc ions in biological phosphorylation and in redox signaling
are already well documented and are part of the spectrum of actions of zinc in cellular
proliferation, differentiation, and cell death.18 There are at least three areas that relate to the
mobilization of zinc ions (i) exocytotic vesicles, (ii) intracellular organelles, and (iii) zinc/thiolate
coordination environments of proteins by oxidation of the sulphur donor(s) of ligands. 13 Zinc is
also used as a metal cofactor in proteins much more frequently than most vitamins. The control
of a fluctuating pool of Zn2+ ions at remarkably low concentrations and with the participation of
many proteins provide a new perspective on the molecular functions of zinc in biology in general
and for the impact of zinc on human health in particular.19
The mobile forms of Zn2+ are thought to play vital roles in biosignaling. For example,
due to the abundance of Zn2+ in the brain Zn2+ may serve as a neurotransmitter in the brain.1
Disruption of transition metal homeostasis in human is involved with pathological conditions in
brain, liver and kidney. Fe, Cu, and Zn dysregulation has been hypothesized to be associated with
Alzheimer disease.20,21,22 Zn deficiency and dyshomeostasis are associated with chronic diseases
such as metabolic syndrome, diabetes and related complications, bone loss, growth retardation
in young children, and neurological and behavioral problems.22,18
1.2.

Protein Bound Zinc
When the entire human genome was scanned for zinc binding signatures among

protein sequences, it was roughly suggested that about 3% of the genes encode zinc proteins.8,11
But from other bioinformatics results, it has been rather strongly predicted that around 10% of
2

the human genome encodes zinc proteins.11 This corresponds to about 2800 of human proteins
that are potentially zinc-binding proteins in vivo.2,8 The estimated number of zinc proteins in the
human zinc proteome demonstrates that there is a widespread use of zinc in protein structure
and function.8 Among transition metals, Zn after iron is the most abundant transition metal in
the human body and the most abundant metal in the brain.23 The number of known zinc proteins
include, 397 hydrolases, 302 ligases, 167 transferases, 43 oxidoreductase, 24 lysases, 957
transcription factors, 221 signaling proteins, 141 transport/storage proteins, 53 proteins with
structural metal sites, 19 proteins in DNA repair, replication and translation, 427 zinc finger
proteins, 456 proteins of unknown function (see Figure 1) .8,11

Figure 1.1: Functional classification of all human zinc-proteins. Most zinc fingers are included among
transcription factors. 427 zinc fingers that are not annotated have been separately maintained.11

The eukaryotic Zn-proteome consists of two major groups of comparable sizes of zinc
proteins: enzymes and transcription factors.4 Available functional information suggests that the

3

large majority of human zinc-binding proteins are involved in the regulation of gene
expression.4,8,24 The most abundant class of zinc-binding proteins in human is that of zinc-fingers,
with Cys4 and Cys2His2 being the most common types of zinc coordination environment.2
Zinc binds as a cofactor to many proteins with a predominant preference of a
tetrahedral coordination structure by four ligands. It most often bound by sulfur and nitrogen
from cysteine and histidine, respectively, and to a lesser extent by oxygen from aspartate and
glutamate.1,8,11,24–27 Primarily Zn2+ ions are found in the form of mononuclear complexes and
structures. In addition, zinc clusters are seen in enzymes such as metallothionein28,26 In zinc
enzymes the necessity for flexibility of the catalytic site toward its substrate leads to the more
dynamic coordination of zinc by ligands from side chains of the protein. Examples are shown in
Figure 1.2.

4

Figure 1.2: The interaction of zinc with ligands.

With few exceptions, zinc ligands in proteins are cysteine (Cys) (S-donor, histidine
(His) (N-donor), or glutamate (Glu)/aspartate (Asp) (O-donor). For cysteine, there is a single mode
of interaction. For histidine, binding occurs with either one of the two nitrogen atoms of the
imidazole ring. For glutamate/aspartate, binding modes include one oxygen, which can be syn or
anti (not shown), or both oxygen of the carboxylate. All three ligands can bridge one or several
zinc ions. For cysteine, there are three bridges. An example of three bridges is the Zn 4S11 cluster
of metallothionein. For histidine, the only bridges known are those between zinc and copper in
superoxide dismutase (SOD1) and between zinc and zinc in the zinc transporter CzrB (Thermus
thermophiles). Aspartate/glutamate can form a bridge with the two oxygens of the carboxylate,

5

for example in alkaline phosphatase and leucine aminopeptidase are referred to the motifs of
zinc binding sites as "cocatalytic" or "coactive" .11, 29
NAD(P)-dependent oxidoreductases occur in virtually all organisms and catalyze the
reversible oxidation of primary and secondary alcohols into aldehydes and ketones,
respectively.28 The first evidence of coordination dynamics in zinc enzymes stemmed from
studies of zinc-dependent horse liver alcohol dehydrogenase (HL) ADH, a member of the family
of medium-chain dehydrogenases/reductases.30, 31 The ADHs in higher eukaryotes (plants and
animals) are usually dimeric, whereas those in prokaryotes and lower eukaryotes (yeast) are
tetrameric. In our study, we used a species of yeast alcohol dehydrogenase from Saccharomyces
cerevisiae. The structure yeast ADH has been determined.28 Each subunit of yeast ADH in the
crystal contains a ‘catalytic’ zinc and a ‘structural’ zinc with no known functional role.28 The
protein ligands of the ‘catalytic’ zinc ion are two cysteines and one histidine. Additionally, four
cysteines bind a second, structural zinc ion relatively far away from the active site. In ADH,
coenzyme (NAD+/NADH) binding induces conformational changes of the protein and alters the
structure of the catalytic metal ion.11
1.3.

Zn2+ trafficking
In order to understand the critical roles of Zn2+ in signaling, it is of utmost

importance to know how metal ions become specifically distributed under steady-state
conditions and temporally redistributed within the cell among the metal-binding structures
during signaling processes. For these reasons the research area of Zn2+ trafficking has risen to the
forefront of metallo-biochemistry over the past few decades.
6

In recognizing Zn2+ as a transient metabolite, it is implied that the concentration of
reactive Zn2+ changes under different circumstances. This pool of Zn2+ might represent free Zn2+
or may stay bound to the proteome. In general, the metabolically active Zn2+ within the cells can
be described as follows.
Zn2+ + L1  Zn -L1

(1.1)

Zn -L1 + L2  Zn-L2 + L1 ………… Zn-Ln + Ln-1

(1.2)

In general, the Zn2+ ions that participate in these cellular reactions are considered
to be mobile; that is, they are able to move among ligands. Typically the status of mobile Zn2+ in
the cellular environment can be termed as, “exchangeable”, “chelatable”, “labile”, or “free”
Zn2+.32,1,33,34 Increased understanding of these reactions has been envisioned in many research
studies through the application of many experimental tools which have been employed to
monitor and assess the facets of the Zn2+ status of the cellular environment.
Studies of the transient Zn2+ is particularly difficult due to the filled d10 electronic
structure. That makes

Zn2+ invisible to visible electronic spectroscopy and paramagnetic

methods. Therefore, the common methods to study iron and copper, for example, can not
equally be employed to investigate Zn2+. These limitations have led researchers to develop other
tools to monitor cellular zinc distribution and function. The cell permeable fluorescent probes
have been designed over the past two decades to study cellular zinc. The objectives are to be
able to observe cellular Zn2+ trafficking, mobilization and signalling using such zinc reactive
fluorophores.33
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1.4.

The zinc sensors
Fluorescent zinc sensors are compounds that undergo a change in fluorescence

emission in the presence of Zn2+. Fluorescence imaging has proven to be an attractive suitable
technique for in vivo monitoring.35 Some examples of zinc fluorophores are shown in Figure 1.3.
These Zn2+ sensors have been the widely used tool to study Zn2+ in the cellular environment. It
has been assumed that these sensors exhibit fluorescence changes when interacting with free
Zn2+ within the cell.
Zn2+ + sensor (S)  Zn-sensor (Zn-S)

(1.3)

Intracellular changes in the free Zn2+ may be evaluated by monitoring fluorescence
changes after a given stimulus. The zinc sensors function properly only in the condition when the
equilibrium constant (K) of the reaction would lie within the range of transient Zn2+ concentration
and the concentration of Zn-S emits enough fluorescence to be observable. When a sensor binds
Zn2+ poorly, the change in fluorescence is insufficient to detect the free Zn2+ concentration.
Moreover, mobilized Zn2+ may bind to adventitous sites within the proteome and among small
molecules.
Zn + L AS  Zn-L AS

(1.4)

Depending on the equilibrium constants the sensor and these other molecules for Zn2+, sensor
will bind and detect Zn2+ in this pool.
∑ Zn-L + S  Zn-S + ∑ L

(1.5)
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Moreover, when the sensor binds strongly to Zn2+ it may chelate zinc from its nontransient Zn-protein pool. Therefore, a more accurate representation of the chemistry involved
in Zn-sensor investigation can be described as follows.
∑ Zn-Protein + sensor  Zn-sensor + ∑ Protein

(1.6)

The extent to which the sensor interacts with the non-transient Zn2+ pool is again
associated with the thermodynamic and kinetic properties of the sensor and the Zn-proteins.
These interactions must be minimal in order to draw any conclusion about the changes in the
transient Zn2+.
One of the most commonly used fluorophores and first to be commercially available is
6-methoxy-(8-p-toluenesulfonamido)quinoline or TSQ. It was first developed as a histochemical
stain for Zn2+ in brain tissue.36,37 TSQ is one of the specific fluorescent probes that gives
fluorescence emission only with Zn2+. This very selective character of sensing Zn2+ makes TSQ an
excellent choice to use as a reporter for Zn2+ trafficking tool. TSQ binds with Zn2+ and makes a
complex in a 2:1 stoichiometric ratio, resulting in the conversion of the non-fluorescent TSQ
molecule into a strongly fluorescent Zn2+ complex.1

9

Figure 1.3: Chemical structures of widely used quinoline based zinc sensors. The crystal structures
of Zn(ZQ)2 and Zn(TSQ)2.1

Using fluorescence microscopy, cells stained with TSQ generally show a punctate staining pattern
that was originally interpreted as revealing localized, high concentrations of Zn2+ in the cellular
environment.1

10

Another zinc sensor that emerged from the same quinoline sulfonamide based
family is (2-methyl-8-p-toluenesulfonamido-6-quinolyloxy)acetate, or Zinquin (ZQ), which largely
replaced TSQ as a Zn2+ sensor. Zinquin was introduced to overcome perceived shortcoming of
TSQ. Since both TSQ and Zn(TSQ)2 are chargeless, cellular efflux of the sensor or the zinc-sensor
complex may occur. To avoid this, an ethyl ester moiety was substituted at the 6 position (R2) of
the quinoline ring (see Figure 1.3). This chargeless molecule passively enters into the cells, and
once inside, is hydrolyzed by intracellular esterases to a negatively charged carboxylic acid,
possibly trapping it into the cell. Additionally, a modification was done by adding a methyl group
at the 2 position of the quinoline ring (Figure 1.3). The methyl group sterically hinders the
formation of square planar and octahedral complexes and favors the tetrahedral complex in a
2:1 binding. This modification also enhances Zinquin’s affinity for Zn2+ in comparison with TSQ.
1.5.

Small molecule ligands of interest
Fluorescent zinc sensors have been widely used as microscopic tools to image

Zn2+on a cellular level. Experiments in the Petering laboratory have established that TSQ and
Zinquin do not form Zn-Ligand complexes when they enter cells. Instead, they form adducts with
Zn-proteins and image a fraction of the Zn-proteome.1,38,39 It is thought that adduct formation
occurs either because Zn2+ binding sites of Zn-proteins are unsaturated with ligands or the Zncoordination sphere can be expanded.
TSQ/ZQ + Zn-proteome  TSQ/ZQ-Zn-proteome

(1.7)

Since TSQ and Zinquin bind to many Zn-proteins, it is hypothesized that other metal binding
ligands, both synthetic and natural, may also bind to the Zn-proteome.
11

The purpose of this dissertation research was to expand on the initial hypothesis of the adduct
forming property of the Zn-proteome to determine the capacity of the Zn-proteome to form
adducts with a variety of synthetic ligands and ligands native to the mammalian cell. Biologically
active 1,10-phenanthroline (Phen), related molecules (See Figure 1.4), some natural
biomolecules, and other synthetic bidentate ligands were investigated for their ability to bind to
Zn-proteome. 1,10-phenanthroline (Phen) is a bidentate ligand, that has long been studied in
biological systems, most recently as a copper complex with potential antitumor activity.40 In this
dissertation study, it was observed that Phen and some other metal binding multidentate ligands
such as glutathione , were able to displace TSQ from the adduct of TSQ-Zn-proteome and form a
non-fluorescent adduct species (Figure 1.4).

Figure 1.4: Some small molecule ligands. The chemical structures of 1,10-phenanthroline, and some
other commonly used ligands in biomedical research.
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In summary, the Zn2+ trafficking is an intriguing field in biochemistry and the
fluorescent biosensors have been particulary employed as a necessary tool to image Zn 2+ in
cellular proteins. The current research demonstrates the capacity of multiple small molecule
multidentate ligands to form adducts with the Zn-proteome.

Project goals
1. To determine whether small molecule multidentate ligands form adducts with the Znproteome.
2. To Identify and investigate whether these small molecule ligands are capable of binding
a model Zn-protein, alcohol dehydrogenase.

13

2. Methods
2.1. Chemicals
All chemicals for experiments were purchased from Sigma-Aldrich, Fischer Scientific and
Worthington Chemicals, unless noted. TSQ (AnaSpec) was solubilized in DMSO, at stock
concentrations of 5 mM, 2mM and 1 mM. Prepared stock solutions of TSQ were kept in the dark
until needed. Stock concentrations were diluted with Tris-HCl for later use in experiments. The
TSQ solutions was used within two weeks of preparation.
Model protein alcohol Dehydrogenase was obtained from Worthington Biochemical.
Approximately, 10-15 mg of lyophilized powder were dissolved in degassed 20 mM Tris-HCl
solution maintained at pH 7.4, and was kept in 4C. Protein samples were used within two weeks
after preparation.
1,10-phenanthroline was purchased from Acros Organic and was solubilized in DMSO to
make a stock solution. The stock solution was always diluted in 20 mM Tris-Cl, pH 7.4 before using
in any reactions.
TCEP (tris(2-carboxyethyl)phosphine) was acquired from Hampton Research. Initially, 68
mM stock solution was prepared in 20 mM Tris-Cl, pH 7.4. The solution was stored in 4C, diluted
and used when it was needed.

2.2. Cell Culture
The LLC-PK1 cell line (transformed kidney epithelial cells from Sus Scrofa (pig)) was purchased
from American Tissue Culture Company (ATCC CL101). Frozen LLC-PK1 cells were thawed after
14

removal from the very low temperature of -80C. The cells were transferred into 15 mL media
(Sigma) contained in culture flasks, and incubated at 37⁰C in the presence of 5-6 % CO2. The LLCPK1 (Sus Scofa (pig)) kidney cell lines were grown in Media M199/HEPES and that was
supplemented with 4% fetal calf serum (FCS). Before the cells were grown, the media was
additionally supplemented with 50 mg/L of antibiotics, both penicillin and streptomycin. The
media was exchanged regularly after 48-72 hours with fresh, complete media. When the cells
reach confluence, the cells were detached with the treatment of 1 mL trypsin/EDTA solution,
centrifuged at 680 x g for 4 minutes and resuspended to complete media around the
concentration of 1-2x10 5 cells/mL and then divided among 100 cm2 cell culture plates.
2.2.1. Viability Assay
In order to find the toxicity of the chemicals that were used in the experiments, a cell
viability test was carried out. The toxicity was assessed in dose and time dependent fashion. 1
mL media M199 containing a suspension of LLC-PK1 cells was grown in a 24 well plate. The plates
were maintained in an incubator for 1-2 days before the experiment was run to check the
cytotoxicity of the ligands.
The viability test utilized the MTT assay that involves the conversion of the tetrazolium
salt 3-(4,5-dimethyl-2-thiazole)-2,5-diphenyl-2H-tetrazolium, bromide (MTT) to formazan.41 The
conversion of MTT to formazan producing formazan salt depends on the mitochondrial electron
pathway, which is necessary for ATP production. MTT was prepared in saline solution at 5 mM
and syringe filtered to sterilize the solution and remove the insoluble particles. MTT was added
to cells grown on 24 well plates and incubated for 2-3 hours at 37C. Media was removed from
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the plates and 1 mL of acidified (0.4 N HCl) isopropanol was added to each well to dissolve the
dark blue formazan crystals. The absorbance of the resultant solution at 570 nm and 630 nm was
measured and the difference of A570-A630 was recorded and calculated as a relative measure of
viability when normalized to zero exposure samples.
2.2.2. Spectrophotometry of Whole Cells
In 100 cm2 cell plates, cells were grown and kept in an incubator until they reached confluency.
When the cells were ready to harvest, the media M199 was removed and the plates were washed
3 times with cold choline phosphate buffered saline (4.7 g NaH2PO4, 1.0 g Na2HPO4, 32.2 g NaCl,
and 25.0 g Choline Chloride in 3.8 L ddH2O). One mL of Dulbecco’s phosphate buffered saline (4.7
g NaH2PO4, 1.0 g Na2HPO4, 32.2 g NaCl, and 25.0 g Choline Chloride in 3.8 L ddH2O) was added
and cells were gently scraped using a rubber scraper. The cells were loosened from their clumped
state into suspension by pipetting up and down two times using a plastic one mL pipette. When
the suspensions from various plates were ready, they were pooled, transferred into a 50 mL
centrifuge tube, and spun down at 680 x g for 4 minutes. The cell pellet was resuspended in a
fluorescence cuvette with a 1 mL aliquot of PBS.
In the spectrofluorometer the background emission was recorded. The fluorescence of
the whole cells was recorded before and after exposure to TSQ, with the latter continuing for 3060 times. The cells were mixed periodically to maintain a homogeneous suspension of the cells.
Additional spectra were recorded until the fluorescence reached a maximum stable level. The
initial background fluorescence spectrum of the cell population was subtracted from subsequent
spectra.
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2.2.3. Cell Lysate Preparation
Sonication was used to open the outer membrane of the cells and also to disrupt the internal
organelle membranes. Cells were collected via centrifugation at 680 x g for 4 minutes at room
temperature. The cell pellet was resuspended in one mL of cold ddH2O per 10 plates of cells. The
harvested cells (see 2.2.2) in DPBS were then transferred to a plastic cut-off tube and were ready
for sonication. Before sonication the flat tip of the sonicator was placed in ice to chill for at least
20 minutes. The cell suspension was sonicated at power 5 for 60 pulses and a total time of 24
seconds. The sonicated cells were transferred to a 15 mL Corex tube until the entire cell
suspension was lysed. For experiments resulting in the isolation of the cellular proteome, 1000
units of Benzonase® nuclease (Sigma) and 500 μM phenylmethanesulfonyl fluoride (PMSF)
protease inhibitor were added to enhance hydrolysis of nucleotides and suppress degradation of
proteins. The sonicates were pooled and spun down in a Sorvall ultracentrifuge 47000 x g for 2025 minutes in 4C temperature. The resulting supernatant is called the ‘cell lysate’. As needed,
the cell lysate was further loaded into a G-75 gel filtration column and separated in a fraction
collector to obtain the “proteome” using the chromatographic technique described in the
procedure below.
2.3 Chromatography
2.3.1. Sephadex G-75 and G-25 Gel Filtration
Various types of size exclusion chromatography were employed to separate complex mixtures.
For the isolation of zinc proteome, Sephadex G-75 and G-25 gel filtration chromatography beads
were purchased from GE Healthcare. Before loading into the column, the beads were soaked in
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20 mM Tris-Cl overnight in refrigerator at 4C, at pH 7.4. The columns were prepared from 0.75
mm round borosilicate glass tubing cut to 90 cm lengths fitted at one end with a plastic stopcock.
A small amount of the glass wool was inserted to the bottom of the column. After overnight
soaking the hydrated G-75 beads were degassed using aspiration in a sidearm flask for 30 minutes
before loading into the column. Approximately, 5 mL of the Sephadex G-75 slurry were then
poured slowly and carefully until the column was homogeneously packed, leaving some room on
the top of the column for approximately 10 mL of solvent buffer. A one liter round bottomed
reservoir flask was attached to the top of the column and filled with Tris-Cl buffer; and the column
was allowed to elute by gravity. The column was washed with at least 100 mL of buffer before
use. Unless otherwise noted, columns were eluted using degassed 20 mM Tris-Cl pH 7.4. When
the columns lost their seal and dried out or when the flow rate exceeded 1 drop every 20 seconds,
the Sephadex beads were replaced.
Typically fractionation involved collecting 25-50 drop fractions, corresponding to 1.0-2.0
mL. For Sephadex G-75 separation, 50 one-mL fractions were collected with a total fractionation
time of 1.5-2.5 hours. Usually, the first 8 fractions represent the void volume, fractions 10-20
contained the high molecular weight (HMW) proteome, larger than 10 kD in molecular weight.
In Sephadex G-25 size exclusion chromatographic separation, fractions 7-13 included the
high molecular weight (HMW) proteome.
2.3.2. HPLC-DEAE Ion Exchange Chromatography
Macro-prep DEAE ion exchange cartridges (5 mL) were purchased from Bio-Rad. The ion
exchange matrix was generated by elution with 5 column volumes of 5 mM Tris-Cl, pH 8.0
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containing 1 M NaCl followed by an additional 5 column volumes with 5 mM Tris-Cl pH 8.0
containing no salt.
Protein solution was loaded into the column using a peristaltic pump, set with the flow rate of 1
mL/min, in a loop, meaning the flow through from the column was directed back into the protein
sample feeding the column. The cycle was performed for 30 minutes, to ensure maximal sample
load onto the DEAE matrix. Elution of the column was performed using a step wise gradient. In
brief, a 10 mL upside down syringe, without the plunger, was connected to the peristaltic pump
using Tygon tubing, which then fed the column.
Using a constant flow rate of 1 mL/min, 7 mL of buffer—5 mM Tris-Cl pH 8.0—was loaded into
the syringe and then allowed to flow until empty. The syringe was then replenished with 7 mL of
new buffer containing a higher salt concentration. A typical stepwise gradient was conducted
using 50 mM NaCl increments from 0-500 mM NaCl. 1 mL fractions were collected from the
column and the conductivity was determined using a Radiometer CDM 3 conductivity meter.
2.4. Analytical Measurement and Determination
2.4.1. Fluorescence spectrophotometry
All fluorescence spectroscopy experiments were carried out using a Hitachi F-4500
spectrofluorimeter in fluorescence acquisition mode. For measuring fluorescence emission
spectra the spectro-fluorometer settings were as follows. Zn-proteins were imaged using an
established fluorophore TSQ. Its excitation wavelength was 370 nm and emission spectra were
acquired between 400-600 nm. Instrument parameters were set to a 10 nm aperture and a 5 nm
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aperture on the photomultiplier emission tube with the lamp set at 950 V. Data acquisition was
carried out in scanning mode at 240 or 1200 nm per second.
2.4.2. Ultraviolet-Visible spectroscopy
A Beckman Coulter, DU® 640 spectrophotometer was used to measure the absorption spectra of
chromophores in samples or absorbances at their max. One-cm quartz or plastic cuvettes were
used for UV (200-400 nm) and visible (400-600 nm) measurements, respectively. The BeerLambert Law was applied to determine the concentration of species based on their measured
absorbances.
A = bc
in which,
A= absorbance
= Extinction Coefficient (M-1 Cm-1)
c= Concentration (M)

2.4.3. Zinc determination using Flame Atomic Absorption Spectroscopy (AAS)
In most experiments, the metal concentrations were measured using flame atomic
absorption spectroscopy (AAS). The GBC AAS instrument was set up with an acetylene torch using
an 80:20 mix of compressed air and acetylene. A zinc element lamp was used for zinc
concentration measurements and a deuterium lamp provided for background correction. Data
acquisition was performed in running mode and was calibrated prior to each run using standards
of 0.5 ppm, 1.0 ppm and 2.0 ppm Zn2+ which corresponds to 7.7 uM, 15.4 uM and 30.8 uM Zn 2+

20

respectively. When, the concentration of Zn2+ was higher than 30 uM, the solution was diluted
and the Zn2+ concentration was remeasured.
2.4.4. Protein Determination via DC Protein Assay
The protein concentration of a given sample was measured using the DC Protein Assay kit from
Bio-Rad Scientific. This is a colorimetric assay based on the reaction of protein with an alkaline
copper tartrate solution followed by the Folin reagent, similar to the Lowry assay.42 Solutions
containing 0.085, 0.17, 0.34, 0.68, 1.36 mg/mL BSA were used as protein standards. In most cases
25 uL of sample were mixed with 125 uL of Reagent A (copper solution) and immediately vortexed
for 5 seconds. One mL of the Reagent B (Folin solution) was then added and the solution was
again vortexed for 5 seconds. After 15 minutes the absorbance at 750 nm was recorded. The
unknown protein concentrations (mg/mL) in the samples were determined using Bovine serum
albumin standard curve.
2.5. Poly Acrylamide Gel Electrophoresis (PAGE)
All gel electrophoretic methods were performed using Novex® NuPAGE® precast gels in
conjunction with the XCell SureLockTM Mini-Cell electrophoresis chamber available from
Invitrogen.
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2.5.1. Native Sodium Dodecyl Sulfate (NSDS) PAGE
NSDS run buffer samples were chilled on ice for 30-40 minutes at 4C before the protein
sample preparation. The NSDS run buffer was composed of 50 mM Tris, 50 mM MOPS, 0.0375%
SDS, pH 7.6.43 The NuPAGE® 12% Bis-Tris pre-cast gels were assembled in the electrophoresis
chamber and a pre-run of the gel was carried out at 150 V for at least 30 minutes using ddH2O as
the run buffer. Protein samples were mixed with 4X sample buffer (100 mM Tris HCl, 150 mM
Tris Base, 10% glycerol, 0.0185 % Coomassie G-250, 0.000625% Phenol Red, pH 8.5) and loaded
into pre-run gels. The electrophoresis chamber was filled with the pre chilled NSDS run buffer.
The electrophoresis was carried out at 150 V, at 4⁰C for 85-90 minutes until the dye front
migrated 60 mm. Gels were stained with TSQ, ligands, and Coomassie Blue as described.
2.6. Gel staining technique
2.6.1. TSQ staining and imaging of gels
Gel staining experiments were performed at the Children’s Environmental Health
Sciences Core Center Laboratory in the School of Freshwater Sciences. Electrophoresis of the
protein samples was carried out using the NSDS-PAGE technique as described in section 2.5.1.
The plastic cassettes of the gel were separated and were gently washed with 100 mL ddH2O two
times. The gel was then carefully transferred for imaging. The gel was transferred into a UVP
EpiChemi II Darkroom UV transilluminator gel box set at the long UV wavelength (approximately
365 nm) setting. Images of the gel were taken using a digital camera with a 470 nm emission filter
and processed using LabWorks software version 4.5. Typical exposure times for fluorescent
images were between 3-10 seconds.
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First a background picture was taken to rule out auto fluorescent protein bands. After
background imaging, the gel was transferred in a shallow disk containing 50 mL of 25 uM TSQ
solution in ddH2O. The gel was soaked and kept in a rotatory shaker for about 40 minutes.
Subsequently the gel was washed with ddH2O two times for 5 minutes. A picture of the stained
gel was captured using the Gel Documentation System as noted before. Next, the gel was treated
with 50 mL 250 uM 1,10-phenanthroline solution in ddH2O for 30 minutes and imaging was done
to see the effect of the ligand on TSQ stained gels.
2.6.2. Coomassie R-250 protein band staining
After gels were removed from their casings, they were placed in a 100 mL fixing solution,
containing 40% methanol and 10% acetic acid, microwaved for 45 seconds, and put on an orbital
shaker for 30-35 minutes. The gel was incubated in the fixing solution for 1 hr with gentle
agitation. This process was followed twice. The fixing solution was decanted and 50 mL of the
staining solution (30 % methanol, 10 % acetic acid, 0.002% Coomassie R-250) added. Gels were
microwaved for 45 seconds and placed on the orbital shaker for overnight. The gels were
destained by incubating in 100 mL of microwaved 8% acetic acid and agitating for 45 minutes.
The destaining solution was replaced and the gel was allowed to destain overnight on a shaker.
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3. Results
Chapter-1 Cellular Chemistry of 1,10-Phenanthroline
3.1. Fluorescence Spectroscopy of Zn(TSQ)2
Zn2+ imaging is important in the cell to understand the biochemistry of zinc. TSQ is a bidentate
Zn-imaging agent (Figure 3.1). Originally, it was thought that TSQ imaged cellular Zn2+.44
However, it has been shown that TSQ actually binds to Zn-proteome not free Zn2+.1

Figure 3.1. 6-Methoxy-(8-p-toluenesulfonamido)quinoline, TSQ

Since TSQ binds to about 15-20% of proteomic - bound Zn2+, it was hypothesized that it could
serve as an indicator of the formation of the adducts with Zn-proteome that involve either
endogenous or exogenous Zn2+ binding ligands (L).
TSQ-Zn-proteome + L  L-Zn-proteome + TSQ

(3.1)

Whereas TSQ-Zn-proteome is fluorescent, L-TSQ-proteome is not; so the loss of fluorescence
decay reaction would signal the presence of L-Zn-proteome. We used 1,10-phenanthroline as the
ligand to test the hypothesis.
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Before investigating reaction 3.1, control experiments were carried out to demonstrate the
appearance of fluorescence upon reaction of Zn2+ with TSQ. One mL 10 uM of TSQ was titrated
with increasing concentration of Zn2+ and over the time the fluorescence intensity change was
monitored. The spectral data were plotted in Figure 3.2 and demonstrated the formation of
Zn(TSQ)2, with a spectral wavelength maximum of 490 nm.

Control: 10 uM TSQ titrated with Zn2+
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Figure 3.2. Fluorescence spectra of TSQ with Zn2+ solution. 10 uM of TSQ in 1 mL of 20 mM Tris-Cl
buffer pH 7.4 was titrated with Zn2+. Using an excitation wavelength of 370 nm, the fluorescence
emission was recorded from 400-600 using a Hitachi F4500 Fluorescence Spectrofluorometer.
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10uM TSQ titrated with Zn2+
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Figure 3.3. Graph of the Concentration of Zn2+ vs. Fluorescence intensity at 490 nm. The graph
confirms the reaction between TSQ and Zn2+ to make a 1:2 complex of Zn(TSQ)2.

Zn2+ + 2TSQ  Zn(TSQ)2 (complex formation at 490 nm)

(3.2)

3.1.1. Zn(Phen)2 complex formation according to the fluorescence data
After the formation of Zn(TSQ)2 Figure 3.2, the product was titrated with the ligand 1,10phenanthroline. The following Figure 3.4, shows that 1,10-phenanthroline can compete with TSQ
for Zn2+ and displace it, resulting in a binary complex formation of Zn(phen)2. During the reaction
the diminishing intensity of the spectra remains centered at 494 nm, indicating that Zn(TSQ)2 is
converted to a Zn-phenanthroline complex and does not form a Zn(TSQ)(Phen) mixed ligand
complex that would emit fluorescence at about 470 nm, which allows to make strong assumption
that 1,10-phenanthroline is capable to bind with Zn2+ in a 2:1 ratio.
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5 uM Zn(TSQ)2 titrated with 1,10-phen
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Figure 3.4. Zn(TSQ)2 complex titration with 1,10-phenanthroline. 5 uM Zn(TSQ)2 was titrated with
1,10-phenanthroline (from the stock solution of 10 mM in DMSO and diluted in Tris-Cl buffer pH 7.4).
A total 10 uL from 30 mM 1,10-phenanthroline was added that makes 300 uM in concentration.
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Figure 3.5. The graph of the titration of Zn(TSQ)2 with 1,10-phenanthroline. Zn(TSQ)2 (5 uM) was
titrated with 1,10-phenanthroline (from the stock solution of 30 mM in DMSO and diluted in Tris-Cl
buffer pH 7.4) up to 300 µM of concentration.

The trend of the titration is shown in Figure 3.5, and it represents that there was a substantial
amount of rapid fluorescence decay (Figure 3.5) observed for the first addition of 1,10phenanthroline. Then for the subsequent additions the reaction continues in a slow progress to
replace TSQ.
Zn2+ + 2TSQ  Zn(TSQ)2

(3.3)

Zn(TSQ)2 + 2 phen  Zn(phen)2 + TSQ

(3.4)
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3.1.2. Time dependent reaction of 1,10-phenanthroline with Zn(TSQ)2 complex

After the study of the concentration dependent titration of the Zn(TSQ)2 complex with Phen a
time dependent study was carried out. In order to do that, 1 mL 10 uM TSQ was allowed to react
with 5 uM Zn2+ and the fluorescence intensity rise was recorded (Figure 3.6) until a maximum
stable fluorescence intensity was reached. After the completion of the reaction, 5 uM Zn(TSQ)2
complex was immediately allowed to react with 60 uM Phen and the reaction was monitored
over the time of 20 minutes (Figure 3.7). 1,10-Phen very quickly displaces TSQ from the Zn(TSQ)2
complex and a Zn(Phen)2 complex was formed which is indicated by the emission max at 490 nm.
The initial fluorescence decay was very rapid followed by a slow displacement of TSQ from the
Zn(TSQ)2 complex which is an indication of the equilibrium of the reaction of the following
reaction.
Zn(TSQ)2 + 2 Phen  Zn(Phen)2 + 2 TSQ

(3.5)
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Figure 3.6. Time dependent reaction of 1,10-Phen and Zn(TSQ)2. 5 uM Zn(TSQ)2 was reacted with 60
uM Phen. Over the time continuing 0.5-20 minute fluorescence change was recorded.
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Time dependent fluorescence change of 5 uM Zn(TSQ)2
with 60 uM Phen
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Figure 3.7. Plot of time dependent reaction of 1,10-phenanthroline with Zn(TSQ)2: The fluorescence
intensity decay of 5 uM Zn(TSQ)2 after the addition of 60 uM 1,10-phenanthroline.

3.2. UV data of Zn(phen)2 complex formation
In accordance with the data of the imaging of Zn(TSQ)2 then the formation of Zn(phen)2, UV-Vis
absorbance spectrophotometry was used to come up with a strong conclusion that Zn(Phen)2
complex formation had occurred. During the titration of Phen with Zn2+, UV spectra were
obtained in the range of 220-320 nm wavelength. In the Figure 3.8, the data were plotted and a
signature spectrum for 1,10-phenanthroline was independently obtained and a spectrum was
recorded at 263 nm region in the UV spectrum. Then the titration with Zn2+ was followed until 42
uM of total Zn2+ (in terms of concentration) addition. It is clear from the data of the Figure 3.8,
that 1,10-phenanthroline makes complex formation in 2:1 ratio with Zn2+. The Zn(Phen)2 complex
shows UV-absorbance maximum intensity at 270 nm wavelength (Figure 3.9). This novel idea
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from the signature proof of the Zn(phen)2 complex formation using UV-Vis spectroscopy further
lead to pursue on the rest of the experiments in the cellular environments.

20 uM phen
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0.9000

add 2 uM
Zn2+
4 uM Zn2+
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8 uM Zn2+
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Figure 3.8. UV-Vis Spectroscopy of titration of Phen with Zn2+. 20 uM of 1,10-phenanthroline was
reacted with 0-42 uM of Zn2+ in 20 mM Tris-Cl, pH 7.4. Absorbance was recorded from 220-320 nm
using a Beckman DU-640 spectrometer. Arrows point to isosbectic points.
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Figure 3.9. The UV-Vis absorbance data of Zn(Phen)2 complex. Zn(phen)2 complex formation at the
two prominent isosbectic points (at 263 and 270 nm) were plotted (data from Figure 3.8).

3.3. Exposing LLC-PK1 whole cells to TSQ in vivo
To image Zn2+ in the living system, LLC-PK1 cells were grown in culture, gently scraped
using phosphate buffered saline DPBS and exposed to TSQ in a plastic cuvette. After exposure of
10 uM TSQ in the cuvette, a time dependent increase in the fluorescence was observed and the
wavelength of the fluorescence maximum recorded. At 470 nm the intensity of fluorescence was
maximum when the cells were directly exposed to TSQ. This gives a clear indication that the Znproteins in the whole cells react with TSQ and form ternary adducts, which fluoresce with a
wavelength maximum at 470 nm region in the emission wavelength. This can be differentiated
readily from the complex formation of Zn(TSQ)2, Figure 3.2, which displays a fluorescence
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wavelength maximum at 494 nm according to the fluorescence data. Hence, supporting the data
that Zn-proteins in the whole cells can make ternary adduct when it is exposed to the sensor TSQ.
Figure 3.10 depicts that the orange line of the highest peak is for the reaction of 1 mL 1X107 LLCPK1 whole cells with 10 uM TSQ, the peak was recorded after the maximum reaction was
completed with TSQ.
Zn-Protein + TSQ ⇄ TSQ-Zn-Protein (ternary adduct formation at 470 nm)

(3.6)

1X107 cells + 10 uM TSQ titrated with Phen
TSQ-Zn-proteome
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Figure 3.10. Fluorescence spectra of TSQ and 1,10-phen exposed cells. 1X107 cells were suspended
in DPBS and reacted with 10 uM TSQ over the time of 20 minutes then the fluorescence spectra were
recorded with the stepwise addition of 1,10-phen.
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Figure 3.11. Diagram of the concentration of 1,10-phenanthroline vs. Fluorescence. The formation
of phen-Zn-protein adduct.

Subsequently, the reaction mixture of LLC-PK1 whole cells stained with TSQ was titrated up to 50
uM 1,10-phenanthroline. The fluorescence spectrum due to the reaction of TSQ with cells was
completely quenched, indicating that ternary adducts of 1,10-phen-Zn-proteins had replaced
from those of TSQ-Zn-proteins. The fluorescence data acquisition was continued for 15 minutes
though no fluorescence change was observed.
From the data and the results from Figures 3.10 and 3.11, the hypothesis was supported that,
1,10-phenanthroline competes with the fluorophore TSQ in the ternary adduct of TSQ-Znproteins and forms 1,10-phen-Zn-proteins. The reaction seems to go to completion indicating
that a high a concentration of 1,10-phenanthroline is required to displace all the TSQ towards
the completion of the reaction yielding the ternary adduct of 1,10-phen-Zn-proteins.
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3.3.1. Reaction of TSQ and 1,10-phenanthroline with the isolated Zn-proteome from the LLCPK1 cell lines
Zn-proteome is the major source of the fluorescence in cells exposed to TSQ.1 Further
characterization of the reaction of the Zn-proteome with TSQ was performed. The pig kidney cell
line LLC-PK1 was grown, harvested and lysed. Subsequently, it was centrifuged in the Sorvall
Ultracentrifuge SS-34 rotor for 20 minutes (at 20,000 ppm and 47,000 X g) and the supernatant
passed through the size exclusion Sephadex G-75 column. Fifty fractions, each containing 1 mL
were eluted from the Sephadex G-75 column chromatography using degassed 20 mM Tris-Cl
buffer pH 7.4. The fractions which absorb at 280 nm in the UV-Vis were pooled and then Zn2+
concentration was measured using atomic absorption spectrophotometry (AAS). Based on the
Zn2+ concentration, 5.7 uM of Zn-proteome was then titrated separately with a concentration up
to 20 uM TSQ. The basal fluorescence of the Zn-proteome was recorded and the fluorescence
enhancement was observed immediately after the TSQ addition with a blue-shifted emission
maxima centered at 470 nm wavelength, data displayed in Figure 3.12.
The mixture of Zn-proteome and TSQ was titrated with 1,10-phenanthroline upto a concentration
of 240 uM. A substantial amount of fluorescence quenching was observed with emission
maximum wavelength centered at 470 nm. The fluorescence was followed for 130 minutes
because the reaction was slow and a gradual loss of fluorescence was observed. Throughout the
reaction, the fluorescence emission maximum remained at 470 nm wavelength. The following
Figure 3.13 was plotted from the experimental data.
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From the above experiment, the results were consistent with the reaction of TSQ-Zn-proteome
ternary adduct with 1,10-phen to form phen-Zn-proteome. The exogenous ligand 1,10phenanthroline competes well with TSQ in a higher concentration and a ternary adduct
formation was revealed by showing the quenching of fluorescence of Phen-Zn-proteome.
The reactions could be summarized as follows:
Zn-proteome + TSQ  TSQ-Zn-proteome

(3.7)

TSQ-Zn-proteome + 1,10-phenanthroline  1,10-phen-Zn-proteome + TSQ

(3.8)
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Figure 3.12. Titration of Zn-proteome with TSQ. 5.7 µM Zn-proteome was titrated upto 20 µM TSQ.
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Figure 3.13. Time dependent plot of the addition of TSQ with Zn-proteome. 5.7 µM Zn-proteome was
titrated upto 20 µM TSQ and over the time of 60 minutes the fluorscence change was monitored.
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Figure 3.14. Reaction of Zn-proteome with TSQ and 1,10-phenanthroline. 5.7 uM of Zn-proteome was
reacted with 20 uM TSQ, then over the time the fluorescence quenching was observed upon stepwise
addition of total 240 uM 1,10-phenanthroline.
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Figure 3.15. The adduct of TSQ-Zn-proteome titration with 1,10-phen. The diagram of concentration
dependent titration of 1,10-phenanthroline with TSQ-Zn-proteome adduct.

When the reaction mixture was chromatographed through Sephadex G-75 size exclusion resin,
the residual fluorescence centered at 470 nm was retained in the proteome region of the
chromatogram that reacted with TSQ and 1,10-phenanthroline respectively, (Figure 3.16).
Further, the reaction mixture did not show any fluorescence in the LMW weight fractions,
suggesting that there was no production of Zn(TSQ)2, according to Figure 3.17, there was also no
sign of Zn2+ in the low molecular weight region, indicating that neither TSQ nor phen removed
Zn2+ from the Zn-proteome. The data of this experiment indicate that 1,10-phenanthroline does
not compete for Zn2+ in Zn-proteins but only forms adducts.
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5.7 uM Zn-proteins + 20 uM TSQ + 240 uM 1,10-phen in G-75 (HMW
fractions)
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Figure 3.16. Sephadex G-75 column chromatography of the mixture of TSQ-Zn-proteome-phen.
High molecular weight fractions from the Sephadex G-75 size exclusion chromatography shows
fluorescence centered at 470 nm.
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Figure 3.17. Results of Sephadex G-75 chromatography of reaction mixture of TSQ-Zn-proteome
and 1,10-phen. The fluorescence and the Zn2+ concentrations of the respective fractions of the
reaction mixture were plotted according to the data from the fluorescence and AAS.

3.3.2. Time dependent study of the isolated Zn-proteome and 1,10-phenanthroline
After the study of the concentration dependent titration of the isolated Zn-proteome from LLCPK1 cells, a time dependent study was carried out. In order to do that, 1 mL 5.7 uM isolated Znproteome was first allowed to react and reach almost saturation with 20 uM TSQ in 60 minutes.
After the completion of this reaction, 200 uM of 1,10-phenanthroline was added immediately
and the reaction was monitored over the time of 55 minutes. 1,10-phenanthroline very quickly
displaces about 40% of the TSQ from the adduct of TSQ-Zn-proteome (Figure 3.18). The following
Figure 3.19 shows a plot of the data of the time dependent reaction of 1,10-phenanthroline and
Zn-proteome. The initial fluorescence quenching is well noticeable by displacing TSQ from the
TSQ-Zn-proteome adduct from Figure 3.18. Due to the higher concentration of 1,10phenanthroline (200 uM) it was an initial 56% of the fluorescence decay, which is consistent with
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the concentration dependent titration (see Figure 3.14) of 1,10-phenanthroline with the adduct
of TSQ-Zn-proteome. Therefore, the reaction is always maintaining an equilibrium and within
the time of 55 minutes after the initial large fluorescence decay there was not any significant
change in fluorescence happened.

5.7 uM Zn-proteins + 20 uM TSQ + time dependent study
with addition of 200 uM 1,10-phenanthroline
1200

+ 200 uM Phen
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Figure 3.18. Time dependent reaction of 1,10-phenanthroline with TSQ-Zn-proteome. 5.7 uM Znproteome was reacted with 20 uM TSQ, then at a time 200 uM of 1,10-phenanthroline was added to
monitor the effect of fluorescence change.
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Time dependent study upon the addition of 200 uM Phen
to TSQ-Zn-proteome
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Figure 3.19. Time dependence of reaction of TSQ-Zn-proteome with 1,10-phenanthroline. The
nature of the time dependent titration with the adduct of TSQ-Zn-proteome and 200 uM 1,10phenanthroline in 55 minutes.

Thus, the reaction between 1,10-phenanthroline and Zn-proteome makes adduct formation and
maintains an equilibrium. The reaction will proceed in forward direction towards completion if
more 1,10-phenanthroline was added.

3.3.3. Reactions of TSQ with the model protein Alcohol Dehydrogenase
To further characterize the reaction of TSQ-Zn-proteome with 1,10-phenanthroline,
yeast alcohol dehydrogenase was used as a model system. Zn-ADH is a tetramer containing two
heterodimers (Zn2αβ)2, each dimer has one structural Zn2+ and a catalytic Zn2+. First, 8.4 uM of
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Zn-ADH in Tris-HCl buffer, pH 7.4 was reacted with 20 uM TSQ and the fluorescence emission
spectrum was monitored over the time of 40 minutes. The resulting spectra were centered at
480 nm, that gives a clear indication of the formation of ternary adduct with TSQ, Figure 3.20.
TSQ + Zn-ADH ⇄ TSQ-Zn-ADH

(3.9)
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Figure 3.20. Reaction with the model protein Zn-Alcohol Dehydrogenase and TSQ. 8.4 uM Zn-ADH
was reacted with 20 uM of TSQ and over the time the fluorescence enhancement was observed until
a maximum intensity of fluorescence was obtained in 40 minutes.

Further, the fluorescent product was reacted with the bidentate ligand of interest 1,10phenanthroline. Upon the addition of 120 uM 1,10-phen, a considerable decrease in the intensity
of fluorescence was observed (Figure 3.21). At the same time, the fluorescence was centered at
480 nm. Based on these results, the reaction of 1,10-phen and Zn-ADH could be constructed as
follows.
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TSQ + Zn-ADH ⇄ TSQ-Zn-ADH (adduct at 480 nm)

(3.10)

TSQ-Zn-ADH + 1,10-phenanthroline ⇄ 1,10-phen-Zn-ADH + TSQ (adduct at 480 nm)

(3.11)

8.4 uM Zn-ADH + 20 uM TSQ: time dependent reaction with 120 uM 1,10-phen
Zn2-ADH
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5000

120 uM (42 min)

4500

43 min

Fluorescence (A.U.)

4000

44 min

3500

45 min

3000

46 min

2500

47 min

2000

48 min

1500

49 min

1000

50 min
55 min

500

60 min

0
400

420

440

460

480

500

520

540

560

580

600

65 min
70 min

Wavelength (nm)

75 min

Figure 3.21. Reaction of TSQ treated Zn-ADH with 120 uM 1,10-phenanthroline. 8.4 µM Zn-ADH +
20 µM TSQ in time dependent reaction with 120 µM 1,10-phenanthroline.

The Figure 3.22 below depicts the biphasic kinetics of Zn-ADH treated with TSQ then
with the bidentate ligand 1,10-phenanthroline. From the kinetics it is also clear that 1,10phenanthroline competes with TSQ to displace it and the rate of the initial reaction is very fast.
The fact that the reaction does not go to completion suggest that it has come to equilibrium. This
is supported by the finding that additional 1,10-phen progressively lowered to final fluorescence
intensity.
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Time dependent reaction: replacement of TSQ from TSQ-Zn-ADH with 120
uM 1,10-phenanthroline
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Figure 3.22. Kinetics of the reaction between TSQ-Zn-ADH treated with 1,10-phenanthroline.

After that, the reaction mixture of TSQ, Zn-ADH and 1,10-phenanthroline was
chromatographed over the Sephadex G-75 size exclusion column and fifty fractions were eluted.
First six fractions collected were called the void fraction volumes. The HMW weight fractions
seven to twenty were analyzed for fluorescence. The spectra showed an enhancement in the
fluorescence centered at 480 nm. Therefore, ternary complex formation had occurred between
TSQ and Zn-ADH. In the presence of 1,10-phenanthroline, the quenching of fluorescence
indicated that an adduct of Zn-ADH with 1,10-phen replaced that with TSQ. There was no
evidence of fluorescence in the LMW fractions eluted from the Sephadex G-75 column.
In order to determine the Zn2+ content in those fractions, Atomic Absorption
Spectrophotometry (AAS) was used and the Zn2+ content was analyzed for each of the individual
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fractions. The combined data of fluorescence and Zn 2+ content are plotted and displayed below
in Figure 3.24. It was demonstrated that the HMW fractions included ternary adducts of 1,10phen.Zn.ADH and that 1,10-phen did not undergo ligand substitution with Zn-ADH to form
Zn(phen)2.

HMW eluted through G-75
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Figure 3.23. Fluorescence emission of Sephadex G-75 fractions of mixture of Zn-ADH+ TSQ +1,10phenanthroline. The mixture was chromatographed using the Sephadex G-75 column
chromatography and HMW fractions were found to display fluorescence centered at 480 nm,
suggesting the ternary adduct formation.
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Figure 3.24. Sephadex G-75 of 1,10-phen-Zn-ADH and Zn2+ content. The high molecular weight
fractions are bound with zinc.

From both the experimental results, using the Zn-proteome and using the model protein
Zn-ADH, it is confirmed that the ligand of interest 1,10-phenanthroline competes with TSQ,
displaces the fluorophore from its Zn-binding sites, and forms the ternary adduct of 1,10-phenZn-ADH.
3.4. Reaction of phen-Zn-proteome with TSQ
3.4.1. Experiments with Zn-proteome
1,10-phenanthroline can compete to displace the fluorophore TSQ from the ternary adduct
of TSQ-Zn-proteome resulting in an equilibrium mixture. The present experiment was designed
to investigate the opposite reaction. In order to examine this reaction, Zn-proteome was
collected and the Zn2+ concentration was measured using AAS. One milliliter of 9.2 uM of Znproteome (in terms of Zn2+ concentration) was reacted first with 18 uM of TSQ and monitored
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for fluorescence enhancement. Upon reaching a stable, maximum fluorescence intensity within
1 hour, the data were recorded and displayed below in Figure 3.25. The fluorescence emission
maximum was centered at 470 nm, that indicated the formation of TSQ-Zn-proteome.
Zn-proteome + TSQ ⇄ TSQ-Zn-Proteome

(3.12)
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Figure 3.25. The fluorescence of 9.2 uM Zn-proteome treated with 18 uM TSQ. One mL 9.2 uM Znproteome was allowed to react with 18 uM TSQ. The fluorescence change was recorded.

At the same time a parallel experiment was carried out using another aliquot of 9.2 uM
Zn-proteome that was treated with 100 uM of 1,10-phenanthroline keeping the total volume one
mL. The solution was mixed well using a plastic pipetter and kept in dark on ice for two hours.
Subsequently, the reaction mixture analyzed by spectrofluorimetry. 1,10-phenanthroline is not a
fluorophore, so only background fluorescence was observed. Then the mixture was treated with
18 uM TSQ to determine whether 1,10-phenanthroline makes any ternary adduct formation with
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Zn-proteome that competes with TSQ. Over time a fluorescence emission spectrum was a
wavelength maximum centered at 470 nm developed indicating formation of TSQ-Zn-proteome
due to the displacement of 1,10-phenanthroline (Figure 3.26). The lower intensity of
fluorescence in comparison with the control of Zn-proteome plus TSQ was due to the equilibrium
formation of the mixture of TSQ-Zn-proteome and 1,10-phen-Zn-proteome. TSQ still needs
longer time to completely displace all the 1,10-phen from the ternary adduct of 1,10-phen-Znproteome.
The spectrum could be interpreted in terms of the following reactions:
Zn-proteome+1,10-phen ⇄ 1,10-phen-Zn-proteome

(3.13)

(non-fluorescent adduct)
1,10-phen-Zn-proteome+TSQ⇄TSQ-Zn-proteome+1,10-phen
(ternary adduct at 470 nm)
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(3.14)
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Figure 3.26. 1,10-phenanthroline treated with Zn-proteome and subsequent reaction upon TSQ
addition. 9.2 uM Zn-proteome was incubated with 100 µM 1,10-phen then reacted with 18 uM TSQ
(in 70 minutes max).

3.4.2. A parallel set of experiments with Alcohol Dehydrogenase
Another set of experiments was carried out to test whether the final state of the reaction
of Zn-ADH with TSQ and 1,10-phenanthroline was independent of the order of addition. A freshly
prepared solution of Zn-ADH in Tris-Cl buffer, pH 7.4 at 25C was assessed for Zn2+ content by
AAS. A concentration of 11 uM Zn2+ in the Zn-ADH was measured. Treating the protein with 20
uM TSQ for an hour yields the maximum fluorescence (Figure 3.27). Immediately the mixture was
treated with 100 uM of 1,10-phenanthroline. A sharp and immediate decrease in fluorescence
was observed and monitored until about an hour to reach equilibrium (Figure 3.27).
Approximately 40% decrease in the fluorescence decay was detected.
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Figure 3.27. The reaction of Zn-ADH + TSQ + 1,10-phenanthroline. 11 uM Zn-ADH (in terms of Zn2+
concentration) was reacted with 20 uM TSQ, subsequently the reaction mixture was treated with 100
uM 1,10-phenanthroline. A ternary adduct formation of 1,10-phen-Zn-ADH was observed based on
the displacement of TSQ and fluorescence emission maximum centered at 470 nm.
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Figure 3.28. Diagram of Fluorescence vs. time (minute) plot. 11 uM Zn-ADH was reacted with 20 uM
TSQ. After the completion of this reaction 100 uM Phen was added and fluorescence change was
recorded.

At the same time, in a separate cuvette, the same stock solution 11 uM Zn2+
containing in Zn-ADH was treated with 100 uM of 1,10-phenanthroline and incubated in dark for
two and half hours. Afterwards, because 1,10-phen-Zn-ADH is a non-fluorescent adduct, only a
baseline was recorded. Upon the addition of 20 uM TSQ, the maximum fluorescence intensity
enhancement was recorded, Figure 3.29. The final fluorescence intensity matched that in Figure
3.27.
The results of this experiment are consistent with rapid kinetics in either direction of
the following reaction. The reactions of this experiment can be described as follows.
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i)

Zn-ADH + TSQ ⇄ TSQ-Zn-ADH
(fluorescence at 470 nm)

(3.15)

TSQ-Zn-ADH+ 1,10- Phen ⇄ Phen-Zn-ADH+ TSQ

(3.16)

(reduced fluorescence)
ii)

Zn-ADH + 1,10- Phen ⇄ Phen-Zn-ADH
(non-fluorescent adduct)

(3.17)

Phen-Zn-ADH + TSQ ⇄ TSQ-Zn-ADH
(enhanced fluorescence at 470 nm)

(3.18)
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Figure 3.29. The reverse addition of 1,10-phen with Zn-ADH then the reaction with TSQ. 11 uM ZnADH (in terms of Zn2+ concentration) was reacted with 100 uM 1,10-phenanthroline. After 2.5 hours
20 uM TSQ was added and the maximum fluorescence intensity was recorded.
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Figure 3.30. The kinetics of reaction 3.15 & 3.16 described in Figure 3.28. After the TSQ was added,
the fluorescence intensity was monitored for nearly 2 hours to see the maximum stable fluorescence.

3.5. Enzyme Activity Assay
To understand more clearly whether the bidentate ligand 1,10-phenanthroline react
with the model protein Zn-ADH, an enzyme activity assay was performed. The assay was
performed by using in 20 mM Tris-Cl buffer, pH 7.4 at 25C containing 1.5 mM NAD, 0-450 mM
EtOH and 19.5 uM of Zn-ADH. The conversion of NAD to NADH was signified by an increase in
absorbance at 340 nm. The initial rate was monitored at 340 nm for 15 seconds. Treatment of
the ligand with 1,10-phenanthroline at a concentration of 50 uM and 80 uM showed reduced
activity of the enzyme by 25% and 50% respectively, still retaining 75% and 50% of its catalytic
activity in terms of the increased concentration with the addition of 1,10-phen. These
experimental data additionally allow in support to conclude that the ligand 1,10-phenanthroline
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is able to react with the enzyme Zn-ADH, and plays a significant role in the inhibition of the
enzyme by showing decreased absorbance when treated with the ligand and follows a MichealisMenten kinetics (Figure 3.31).
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Figure 3.31. Enzyme activity assay of Zn-ADH. The assay was performed in 20 mM Tris-Cl pH 7.4 at
25C containing 1.5 mM NAD, 0-450 mM ethanol and 19.5 uM of the enzyme Zn-ADH (in terms of
Zn2+ concentration). Initial rate was monitored at 340 nm for 15 seconds. Results were compared
with the enzyme ADH and not-reacted 1,10-phenanthroline.
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3.6. TSQ Staining of NSDS-PAGE gels and the reaction of Zn-proteome with TSQ and 1,10phenanthroline

The proteomic Zn2+ competition for adduct formation between TSQ and 1,10-phen has been
demonstrated. Next, competition at the individual Zn-proteome level was investigated. Sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is the most commonly used
technique to obtain high resolution separation of analytical mixtures of proteins. 43 But the SDSPAGE method does not keep the proteome in its native state along with its metal cofactors. For
the purpose of maintaining the integrity of the proteome, we used Dr. Andrew Nowakowski’s
technique of Native SDS-PAGE high resolution electrophoretic separation (NSDS-PAGE) of
proteins with retention of native properties including bound metal ions.43 To begin the study, 5
X 108 LLC-PK1 cells grown in culture and collected, lysed via sonication, and 500 mM
phenylmethylsulfonyl fluoride (PMSF) and 1000 U Benzonase © nuclease (Sigma) were added to
inhibit proteolysis and increase nuclease activity, respectively. The sonicate was centrifuged at
47 000 X g for 30 minutes at 4⁰C. The supernatant was run over a Sepahadex G-25 gel filtration
column using degassed 5mM Tris-Cl buffer, pH 8.0. The HMW proteome fractions exhibiting
absorbance at 280 nm were pooled together and subsequently loaded onto a Macro-Prep DEAEHPLC anion exchange column (Bio-Rad) for further separation. The column was eluted with 5 mM
Tris-Cl pH 8.0 with a step gradient from 0-500 mM NaCl. The fractions eluted from the DEAEHPLC column separation were measured for conductance and absorbance at 280 nm (See Figure
3.32). Select fractions were concentrated using a Millipore centrifuge filter (3000 Da molecular
weight cut-off) that was spun at 12,000 X g for 20 minutes at 4⁰C. Samples were desalted by
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repeating the concentration three times, washing the protein samples with fresh 5 mM Tris-Cl
pH 8.0 between each concentration.

Gradient DEAE-HPLC elution of LLC-PK1 Zn-proteome
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Figure 3.32. Gradient DEAE elution of isolated LLC-PK1 proteome: Isolated LLC-PK1 proteome in 5
mM Tris-Cl pH 8.0 was loaded onto a 5 mL Macro-Prep DEAE column. The column was eluted step
wise 0-500 mM NaCl up to final concentration 500 mM NaCl in 5 mM Tris-Cl pH 8.0. Conductivity and
absorbance at 280 nm were recorded.

In order to understand and clearly see the effect of 1,10-phenanthroline and its adduct formation
properties with the isolated Zn-proteins, selected fractions from the gradient elution were loaded
onto in a NuPAGE Novex 12% Bis-Tris 1.0 mm minigels (Invitrogen) and electrophoresed using
the NSDS-PAGE method. After the electrophoresis was complete, the cassette was separated and
the gel was taken out and washed with 100 mL ddH2O.
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For TSQ staining, gels were soaked in 50 mL of ddH2O containing 25 mM TSQ on a rotary shaker
for 40 minutes and washed twice with fresh ddH2O for 5 minutes before fluorescent images were
recorded (See Figure 3.33(A)). Gels were then additionally incubated in 50 mL of ddH2O
containing 200 µM 1,10-phenanthroline for 30 minutes before subsequent images were captured
(See Figure 3.33(B).
To visualize the results of the reaction of separated Zn-proteome with TSQ and then 1,10-phen,
the reacted gel were transferred to a UVP EpiChemi II Darkroom UV transilluminator gel box and
excited at 365 nm (long wavelength UV setting), the excitation wavelength of TSQ. Fluorescent
images were recorded with a digital camera with a 470 nm emission filter using a three second
exposure time.
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Figure 3.33. Imaging of the reaction of 1,10-Phen with TSQ-Zn-Proteins. DEAE fractions of proteome
were separated by the method of Native SDS-PAGE that retains protein bound Zn2+. In A selected
bands of Zn-proteome fluoresce brightly when stained with 25 µM TSQ. In B, after the reaction with
200 µM 1,10-phentharoline the brightly fluoresced bands with TSQ is quite faint, that supports of the
adduct formation of Phen-Zn-proteome replacing TSQ from the adduct of TSQ-Zn-proteome.

According to Figure 3.33(A) it is evident that some of the bands show bright fluorescence with
TSQ. However, these bands were mostly quenched after the reaction with 200 µM 1,10phenanthroline. This experiment specifically supports the conclusion that both TSQ and 1,10phenanthroline are able to make adducts with specific proteins in the Zn-proteome.
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Chapter-2 Cellular Chemistry of Glutathione
3.7. Cellular Quenching of TSQ Fluorescence using Glutathione (GSH)
Cellular glutathione is an important tripeptide Figure 3.34. GSH plays an important role as an
antioxidant in plants, animals, fungi and some other bacteria and archea, preventing damage to
important cellular components caused by reactive oxygen species such as free radicals and
peroxides.45 It does so through its sulfhydryl group in its chemical structure; thiol (-SH) groups
are reducing agents. GSH exists in the concentration range of 1-10 mM in animal cells.46

Figure 3.34. Chemical structure of glutathione

In the current experiments, glutathione was used as a ligand to see if it has any binding capacity
with the cellular Zn-proteins. To begin, in accordance with the previous chapter-1 of this thesis,
we used the TSQ-Zn-proteome as a reporter to study the binding of ligands to the Zn-proteome.
The same hypothesis was applied here. If Glutathione reacts in the cellular level with Znproteome, the effect can be monitored upon ligand substitution for the sensor TSQ from the
ternary adduct of TSQ-Zn-proteome. The reaction could be described as follows:

Zn-proteome + TSQ  TSQ-Zn-proteome (470 nm)

(3.19)

TSQ-Zn-proteome + GSH (reduced)  GS-Zn-proteome + TSQ (470 nm) + H+

(3.20)

61

When one mL of 4.5 uM Zn-proteome was reacted with 10 uM of TSQ a maximum fluorescence
emission was attained in about 70 minutes due to the formation of TSQ-Zn-proteome. Figure
3.35 shows the fluorescence spectrum of the ternary adduct centered at 472 nm. The ternary
adduct of TSQ-Zn-proteome was subsequently used to monitor the effect of the reaction of
glutathione (GSH) with Zn-proteome.
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Figure 3.35. Time dependent reaction of Zn-proteome with TSQ. One mL of Zn-proteome (4.5 uM
Zn2+) was titrated with 10 uM of TSQ over the time of 70 minutes. A stock concentration of 2 mM TSQ
(in DMSO) was used for the experiment.

A stock solution of 10 mM glutathione (GSH) was prepared in 15 mL 20 mM degassed Tris-Cl, pH
7.4 keeping the solution at room temperature. Titration of TSQ-Zn-proteome with glutathione
started at 50 uM and increased gradually to 1.15 mM. Figure 3.36 displays the whole reaction,
which was carried out over 2.5 hours. The fluorescence quenching happens in a biphasic manner
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without changing in the remaining fluorescence spectrum. From the data of Figure 3.37, it is
evident that glutathione competes to replace TSQ resulting in the gradual loss of the intensity of
TSQ-Zn-proteome resulting in the formation of GS-Zn-proteome.
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Figure 3.36. The ternary adduct TSQ-Zn-proteome was titrated with Glutathione (GSH). A 10 mM
Glutathione (GSH) solution was prepared in 20 mM Tris-Cl, pH 7.4. A total of 1.15 mM concentration
of glutathione was added and time dependent changes in fluorescence were recorded.
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Figure 3.37. Concentration dependence of the reaction of TSQ-Zn-proteome with GSH.

3.8. Cellular Chemistry of TCEP (tris(2-carboxyethyl)phosphine)
After finding evidence from the reaction of glutathione with TSQ-Zn-proteins that GSH forms a
ternary adduct with Zn-proteins, other plausible ligands such as Histidine, 8-Hydroxyquinoline,
Dimethyldithiocarbamic acid and TCEP (Tris(2-carboxyethyl)phosphine) were studied. The first
was TCEP, which is used as a reducing agent to keep protein thiols from oxidizing to disulfides.

(3.21)
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Glutathione reduces disulfide bonds formed within cytoplasmic proteins to cysteines in that
disulfide exchange, redox reaction. In the process, glutathione is converted to its oxidized form
glutathione disulfide (GSSG). The reaction could be expressed as follows.
2 GSH + R-S-S-R  GS-SG + 2RSH

(3.22)

There has been much research to find a chemical that could serve as an effective thiol protectant
compound. TCEP has recently been introduced and is commercially available as such a reagent.47
The properties of TCEP have been attractive especially in studies of proteins which can be
sensitive to sulfhydryl oxidation. TCEP carries three carboxyl groups in its structure and these
carboxyl groups might serve as a multidentate ligand that bind to Zn-proteins.

Figure 3.38: Chemical structure of TCEP

Experiments were undertaken to investigate whether TCEP does also exhibit binding properties
with the Zn-proteome. To investigate this novel hypothesis, the following experiments were
carried out.
TCEP is stable in aqueous solution at pH values above 7.5.48 TCEP was dissolved in 20 mM Tris-Cl
buffer, pH 7.4 and a 68 mM stock solution was prepared. At first, a control experiment was run
to determine if TCEP makes a complex formation with the Zn2+ solution. For this reaction, 10 uM
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of TSQ was reacted with 10 uM Zn2+ making a total volume of one mL in a cuvette to study
fluorescence, with excitation wavelength at 370 nm. The reaction was monitored over the time
for 40 minutes, and a maximum fluorescence was observed and recorded. According to Figure
3.39, the spectrum was recorded with the maximum intensity of fluorescence centered at 490
nm, consistent with the formation of Zn(TSQ)2. Subsequently, the product was titrated with TCEP,
taking aliquots from the stock solution of 68 mM. From the Figure 3.39 it is indicative that 0 1.18 mM TCEP modestly quenched the intensity of the fluorescence without changing
fluorescence maxima that was centered at 490 nm. This result suggested that TCEP formed a
complex with Zn2+ that was less stable than Zn(TSQ)2.

blank 10 uM tsq

10 uM TSQ + 10 uM Zn2+ + 1.8 mM TCEP

10 uM Zn2+ (max)
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136 uM tcep (0.5 min)
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Figure 3.39. Titration of Zn(TSQ)2 complex with TCEP. A total of 1.18 mM concentration of TCEP was
added over 30 minutes.

66

3.8.1. The cellular chemistry of TCEP with LLC-PK1 cell lysate
LLC-PK1 cell lysate not only consists of the Zn-proteome but it also contains small molecular size
peptides such as glutathione. The previous experiment with GSH indicated that it can form
adducts with components of the Zn-proteome. Thus, in the cell lysate some of the glutathione
may be reversibly stay bound as ternary adducts with Zn-proteins. In that case, of cell lysate, if
the fluorophore TSQ added to lysate to image out Zn-proteins, Glutathione (GSH) may partially
inhibit the availability of the Zn-proteome to react with TSQ. On the other hand, if TCEP is injected
in the cell lysate, it will prevent glutathione from being oxidized and will help retain the Znproteome in its native reduced state react upon the addition of TSQ.
If this hypothesis is correct, a reduced amount of fluorescence intensity might be resulting in for
the reaction of TSQ with Zn-proteome when the cell lysate is treated with TCEP. The idea could
be presented as the following reactions in light of the presence of TCEP.
Cellular GSH + Zn-proteome  GS-Zn-proteome

(3.23)

Zn-proteome + TSQ  TSQ-Zn-proteome (fluorescent emission at 470 nm)

(3.24)

Based on the hypothesis, an experiment was carried out growing 10 plates (10X108 cells) of LLCPK1 cell lines in the Media M199. After the cells reached confluence, they were harvested using
DPBS, then sonicated and centrifuged using Sorvall SS-34 for 20 minutes. The cell supernatant
was collected and diluted to total volume of 3 mL using 20 mM Tris-Cl buffer, pH 7.4. From the
diluted supernatant cell lysate, two parallel experiments were run.
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i)

One mL of the LLC-PK1 cell lysate containing 10 uM Zn2+ concentration was treated
with 1 mM TCEP (from 68 mM stock solution) and kept in the dark for an hour. Then
it was exposed to 10 µM TSQ.

ii)

Another one mL aliquots of the LLC-PK1 cell lysate, containing the same 10 uM Zn2+
concentration was used directly for the reaction with the fluorophore TSQ.

Part-i: LLC-PK1 cell lysate treated with TCEP
The LLC-PK1 cell lysate treated with 1 mM TCEP was titrated with TSQ in two separate additions
of 10 uM and a total of 20 uM concentration of TSQ was added using from a stock solution of 5
mM TSQ. In the following Figure 3.40 the results were plotted. The fluorescence intensity was
later compared with the cell lysate without treated with TCEP (see part ii).
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Figure 3.40. Reaction of TCEP (1 mM) treated LLC-PK1 cells exposed to TSQ. One mL LLC-PK1 cell
lysate was treated with 1 mM TCEP then stepwise reacted with up to 20 uM TSQ and the changes in
the fluorescence intensities were recorded.

The ternary adduct formation, results in TSQ-Zn-proteome, was eluted through Sephadex G-75
gel filtration column and 40 fractions were collected. After eluting the reaction mixture, all the
fluorescence (Figure 3.41) and Zn2+ concentration (Figure 3.42) was found located in the high
molecular weight (HMW) proteomic region. The fluorescence wavelength maximum remained at
470 nm, Figure 3.41, which further supporting the formation of a ternary adduct.
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Figure 3.41. Sephadex G-75 chromatography of cell lysate treated with TCEP + TSQ. Reaction
mixture of LLC-PK1 cell lysate treated with TCEP then reacted with TSQ, was chromatographed
through Sephadex G-75 gel filtration column, using degassed 20 mM Tris-Cl buffer pH 7.4.
Fluorescence was recorded for each fraction.
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LLC-PK1 cell lysate treated with TCEP + TSQ in Sephadex G-75 column
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Figure 3.42. LLC-PK1 cell lysate treated with TCEP + TSQ. The mixture was chromatographed using
Sephadex G-75 gel filtration column, the fluorescence and Zn2+ concentration were recorded for the
fractions eluted from the column.

Part-ii: LLC-PK1 cell lysate without TCEP
The other one mL cell lysate mentioned above was directly titrated with TSQ with a total of 20 uM
concentration in two separate additions to observe the maximum intensity of fluorescence emission.
Again, the results demonstrated the ternary adduct formation with the emission maximum centered
at 470 nm, Figure 3.43.
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Figure 3.43. Fluorescence of LLC-PK1 cell lysate + TSQ (without TCEP). One mL 10 uM of the LLC-PK1
cell lysate was reacted with stepwise addition of total 20 uM TSQ and the fluorescence change was
monitored over the time continued until 63 minutes.

Further the reaction mixture was eluted through Sephadex G-75 and 40 fractions each containing
one mL were collected. The fluorescence data Figure 3.44 and the Zn2+ analysis Figure 3.45, both
support that none has mobilized Zn2+ in LMW region, therefore Zn2+ is located at the HMW
proteomic region.
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Figure 3.44. The LLC-PK1 cell lysate (without TCEP) + TSQ eluted in Sephadex G-75 gel filtration
column. The reaction mixture was eluted in Sephadex G-75 column using degassed 20 mM Tris-Cl pH
7.4. The fractions were collected and the fluorescence was recorded for each fraction.
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Figure 3.45. In Sephadex G-75 chromatography the reaction mixture of LLC-PK1 cell lysate + TSQ
was eluted. The fluorescence of the eluted fractions and the Zn2+ concentration were recorded.
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Based on the data a comparison was made about the fluorescence intensity in Figure 3.40 and
3.43. Both the results of part-i and part-ii displayed above. A significant loss, about 40% of
fluorescence intensity was observed and recorded for the cell lysate treated with TCEP. This
result supports the hypothesis that TCEP protects glutathione against oxidation, limiting the
availability of Zn-proteome to react with TSQ and resulting in lower fluorescence intensity.
To investigate this possibility again, experiments were repeated the model protein Alcohol
Dehydrogenase (Section 3.8.2).

3.8.2. Chemistry of TCEP with the model protein Alcohol Dehydrogenase
A fresh solution of 17.5 uM Zn-ADH was prepared in 20 mM degassed Tris-Cl at pH 7.4. One mL
of Zn-ADH was transferred in a cuvette and the fluorescence was recorded. Then the Zn-ADH
solution was reacted with 35 uM of TSQ for 20 minutes, and the change in fluorescence intensity
was monitored to determine when the maximum intensity was achieved. As expected ternary
adduct formation at a blue shifted emission maxima centered at 470 nm was observed, (Figure
3.46). Subsequently, the mixture was titrated with increasing concentration of TCEP up to 1.18
mM of total concentration. The results displayed in Figure 3.47.
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Figure 3.46. Titration of Zn-ADH with TSQ. 17.5 uM of Zn-ADH in 20 mM degassed Tris-Cl pH 7.4 was
reacted with 35 uM TSQ over 20 minutes to obtain the maximum fluorescence spectrum.

The titration of Zn-ADH with TCEP did not show any significant fluorescence change. The titration
was continued until 40 minutes. Thus, it was concluded that TCEP does not compete with TSQ
for Zn bound to ADH.
Zn-ADH + TSQ  TSQ-Zn-ADH

(3.25)

TSQ-Zn-ADH + TCEP  No reaction

(3.26)
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17.5 uM Zn-ADH + 35 uM TSQ + 1.18 mM TCEP
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Figure 3.47. The adduct of TSQ-Zn-ADH titration with TCEP. 17.5 uM Zn-ADH was reacted with 35
uM TSQ then the adduct of TSQ-Zn-ADH was titrated with a total concentration up to 1.18 mM TCEP.
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4. Discussion

The study of Zn-proteins and their function in human health and disease requires effective tools
for zinc bioimaging. Such tools have recently focused on the use of

fluorescent zinc

sensors.35,49,50,38 In spite of the rapid advances in zinc and all other metal ion sensing, however,
the current available probes will need additional modifications and improvement to overcome
several remaining challenges. Such remaining improvements include reagents with improved
metal and oxidation-state specificity, brighter fluorescent turn-on responses, and targetability to
specific subcellular locations. That would provide the ability to perform new types of molecular
imaging experiments.50 In addition to that, research using other biologically important small
molecules may provide new insights into the functions of zinc proteins. The specific goal in this
dissertation work was studying some small molecule ligands and their adduct formation with zinc
proteins. The role of adduct formation between zinc proteins and biologically active small
molecules may play a role in anti-tumor activity. Also the adduct formation with these nonfluorescent small molecules can lend new insight towards the study of zinc imaging.

1,10-phenanthroline and its copper complexes have been investigated for their roles in biological
activities, such as anti-tumor, anti-Candida, anti-mycobacterial and anti-microbial effects.

51

A

recent study undertaken by C. Deegan, provided the first thorough examination of the potential
application of phenanthroline and its metal based complexes as novel therapeutic agents for the
treatment of cancer.52,40 Another group expanded this to include such aromatic N-containing
ligands as pyridine and imidazole. 1,10-phenanthroline and its analogues have donor properties

77

that are somewhat similar to the purine and pyrimidine bases and are showing a promising role
as antitumor agents.51

The work of this thesis is based on studies by the Petering group, which shows that the zinc
fluorophore TSQ binds with the Zn-proteome, when it undergoes reaction both in vitro and in
vivo.1 Ternary adduct formation is indicated by increased fluorescent intensity and unique,
altered wavelength maxima centered near 470 nm.1 Similar results were observed when TSQ
was incubated with the model protein Alcohol Dehydrogenase (ADH). The lack of a 490 nm peak
emission wavelength (Zn(TSQ)2) in the proteome system indicated that TSQ imaged the zinc
proteome as a ternary adduct (TSQ-Zn-Proteome).1,5 Therefore, the observed fluorescence
(fluorescence microscopy or spectrofluorometry) of TSQ stained cells should be interpreted as
the fluorescence of the TSQ-Zn-proteome, rather than assuming that there are pockets of free or
labile zinc in the cells that react with TSQ to form Zn(TSQ)2 as was hypothesized previously.11,1
These pioneering results with TSQ were generalized by Dr. Andrew Nowakowski in 8 different
cell lines. My research work replicated these results using the LLC-PK1 cell line for the purpose of
this thesis.

Experiments have been done to examine the hypothesis that biologically active metal binding
ligands (L) such as 1,10-phenanthroline, the cellular tripeptide glutathione, some other
multidentate ligands also bind as adducts to proteins in the zinc proteome. We used the following
reactions to shed light on this topic and carry out the relevant experiments.
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Zn-proteome + TSQ  TSQ-Zn-proteome (fluorescent)

(4.1)

TSQ-Zn-proteome + L  L-Zn-Proteome + TSQ (non-fluorescent)

(4.2)

In order to study the biologically active small molecules, TSQ-Zn-proteome was used as a reporter
to evaluate whether competitive formation of non-fluorescent ternary adduct happens (see
reaction 4.1 and 4.2).

The results show that 1,10-phenanthroline replaces most of the TSQ in a multiphasic manner.
Figure 3.18 clearly shows that Phen did not mobilize (chelate) Zn2+ from the isolated Zn-proteome
as the mechanism by which TSQ fluorescence is quenched. Thus the reaction results in the
formation of Phen-Zn-proteome ternary adducts as Phen displaces TSQ from TSQ-Zn-proteome
and quenches its fluorescence.
TSQ-Zn-proteome + 1,10-phenanthroline  Phen-Zn-proteome + TSQ

(4.3)

Next, the capacity of the ligand 1,10-phenathroline to replace TSQ was tested in vivo using the
pig kidney cell line LLC-PK1 . It is evident from the results (Figure 3.10) that 1,10-phenanthroline
is able to compete with TSQ in the intact cells as it does with the isolated Zn-proteome. Previous
studies have suggested that Phen might sequester Zn from Zn-proteome or bind Fe or Cu in cells
leading to redox reactions and the production of reactive oxygen species. 40 Any of these might
be responsible for the observed cytotoxicity of Phen. The present study shows that reaction of
Phen with the Zn-proteins can also occur forming a ternary adduct. Therefore, some of the
biological effects of 1,10-phenathroline may be attributable to adduct formation with the Znproteins.
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The Sephadex G-75 column separation chromatography of the reaction mixture, strongly support
that Phen only competes to replace TSQ in the high molecular weight proteins. There was no
fluorescence in the low molecular weight fractions. Moreover, no trace of Zn2+ was detected in
the metal analysis experiment of those fractions (see Figure 3.17).

To support the validity of the results above, using the pig kidney cell line, LLC-PK1 and its isolated
Zn-proteome, the model protein alcohol dehydrogenase (ADH) was also used. Carrying out the
same set of experiments with Zn-Alcohol Dehydrogenase, a well-defined Zn-protein, confirmed
the idea that Phen makes ternary adduct formation replacing the zinc imaging fluorophore TSQ.
Zn-ADH + TSQ ⇄ TSQ-Zn-ADH

(fluorescence at 470 nm)

TSQ-Zn-ADH + 1,10- Phen ⇄ Phen-Zn-ADH + TSQ (reduced fluorescence)

(4.4)
(4.5)

In light of the support for the hypothesis that the Zn-proteome can form adduct species with
Phen, an additional experiment was carried out, involving enzyme activity assay. In the enzyme
activity assay the conversion of NAD+ to NADH was utilized to monitor the initial rate of catalysis.
Upon additions of 50 uM and 80 uM 1,10-phenanthroline, the rate of the reaction was reduced
28% and 50%. The enzyme activity assay data brings forth the notion of the ability of 1,10Phenanthroline to inhibit the enzyme Zn-Alcohol Dehydrogenase.

Finally, an experiment that supported Zn-proteome into individual proteins using NSDS-PAGE
method. The proteome were then treated with TSQ and then with 1,10-phenanthroline, (Figure
3.33) to visualize adduct formation properties of 1,10-phenanthroline with distinct proteomic
region. The TSQ treated Zn-proteome bands brightly fluoresce due to the formation of TSQ-Zn80

proteome (Figure 3.33A). After subsequent addition of 1,10-phenanthroline, the fluorescence
decayed as Phen-Zn-proteome (Figure 3.33B), replaced TSQ-Zn-proteome.

Hence, the exposure of cells to Phen or other small molecule ligands to the whole proteome bear
the potential to perturb the functions of proteins. This quenching mechanism indicates that the
zinc sensor, TSQ, which partially saturates the Zn-proteome, may serve as a reporter for
monitoring the capacity of small molecule metal-binding ligands to react with Zn-proteome and
generate adduct species, L-Zn-proteome.
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Another chapter of this thesis encompasses an important cellular ligand glutathione (GSH).
Glutathione is a tripeptide, glu-cys-gly. It is typically present at high concentration level (1-10
mM) in cells and is thus both the most prevalent cellular thiol and the most abundant low
molecular weight molecule.46 In the cell, glutathione plays a crucial role as an antioxidant. It
carries one sulfhydryl group in its structure (Figure 3.34). The sulfhydryl groups help to maintain
the intracellular redox state and protect the cells against oxidative damage.45 Our aim was to see
if glutathione (GSH) being a small molecule and a tripeptide does have any properties of ternary
adduct formation with the labile pool of zinc in the Zn-proteome.

We carried out experiments to image Zn-proteome with TSQ to form the adduct of TSQ-Znproteome (Figure 3.35) and titrated with GSH. The data of this experiment showed that GSH is
able to form a ternary adduct of GS-Zn-proteome (Figure 3.36) with GSH replacing TSQ from the
adduct of TSQ-Zn-proteome at a higher concentration (about 1.15 mM). This positive result led
to experiments with LLC-PK1 cell lysate.

The ligand tris(2-carboxyethyl)phosphine or TCEP is conventionally used in biochemical research
studies for the protection of thiol (-SH) groups by preventing their oxidation. As such, it helps to
maintain the structure and proper activity of many proteins.48,53,54 Previous research studies with
TCEP gives ample information that it maintains the thiol (-SH) rich proteins in their reduced state
and it also helps in enhancing the rate of the reaction of cysteine-rich peptides.55,56,57 We decided
to study the effect of the addition of TCEP in the LLC-PK1 cell lysate whether it helps to maintain
GSH in its reduced state.
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In order to understand the effect of TCEP in preserving thiols in the cell lysate in its native reduced
state, a control experiment with Zn2+ solution was carried out. When 10 uM of Zn2+ was reacted
with 10 uM TSQ it was observed that Zn(TSQ)2 complex was formed and the emission wavelength
being centered at 490 nm. When TCEP was reacted with the complex Zn(TSQ)2 it was found that
large concentration of TCEP can to a small extent replace TSQ from the Zn(TSQ)2 complex forming
a Zn(TCEP)2 complex. This provided the initial evidence that TCEP is able to form the Zn(TCEP)2
complex (see Figure 3.39).

Then the impetus was to investigate the effect of TCEP in the cell lysate. To understand that
possibility we carried out experiments with LLC-PK1 cell lysate. In the LLC-PK1 cell lysate, not only
are Zn-proteins available, but glutathione and other small molecular weight proteins are present.
We followed up the idea of adduct formation of GSH with Zn-proteome (Figure 3.36). Because
GSH is able to form ternary adduct with zinc in the Zn-proteome, it will be partially limiting the
availability of Zn-proteome in the cell lysate to react with TSQ. Previous studies in our lab had
shown that GSH undergoes oxidation once cells are lysed and the lysate is exposed to air. If TCEP
protects the thiol (-SH) groups from being oxidized to GS-SG, then our expectation was to see
lower fluorescence intensity when the LLC-PK1 cell lysate was treated with TCEP. We found
evidence to support this hypothesis from the data. The LLC-PK1 cell lysate treated with TCEP was
compared with data of LLC-PK1 cell lysate not treated TCEP (Figure 3.40 and 3.43). The TCEP
treated cell lysate revealed lower fluorescence intensity when incubated with TSQ compared to
the non-treated cell lysate (Figure 3.40 and 3.43). Both sets of experiments were carried out at
the same time keeping the same stoichiometry of the cellular environment, the reagents used,
and the parameters in the fluorimeter (see chapter 2, part-i and part-ii).
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In all of the experiments above, when the pool of the mixture containing adducts of GS-Znproteome and TSQ-Zn-proteome in the cell lysates were chromatographed over the Sephadex G75 column, only the HMW proteome fractions displayed fluorescence and Zn2+ (Figure 3.42 and
3.45). There was neither fluorescence nor Zn2+ in the LMW fractions. These results lead to
conclusion that GSH does make ternary adducts within the Zn-proteome in the cell lysate.
However, we were not able to directly measure GSH concentration because TCEP interfered with
the colorimetric reaction. Future experiments will need to determine GSH by another method.

Assuming our interpretation is correct, then GS-Zn-proteome complexes may exist in cells. Since
many Zn2+ binding sites contain thiol ligands, directly bound GSH may be particularly effective
protecting these sites from oxidation.
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